Prevnos

We use "colored dots" to detect and screen for cancer.

  • Stage Prototype Ready
  • Industry Healthcare Services
  • Location New York, NY, US
  • Currency USD
  • Founded January 2016
  • Employees 1
  • Incorporation Type C-corp
  • Website prevnos.com

Company Summary

Prevnos is a cancer diagnostics company that uses simple "colored dots" to characterize cancer genes in cells. We operate in 4 segments: consumables, capital equipment, software, and clinical trials. Our tests are highly reimbursable, and our end-users include CLIA-certified testing labs, big pharma companies, high-complexity genetics labs, cytogenetics facilities, and clinical research organizations.

Team

  • Mohammed Harris
    Founder and CEO

    Degrees from Rutgers, Johns Hopkins, UMDNJ. 10+ certificates from various schools. ~10 years experience in FISH diagnostics. Worked for a private genetics startup as Director of Research prior to its successful acquisition in March 2015. Also worked for Reproductive Medicine Associates, BioReference Laboratories, and PLUS Diagnostics. Know the CLIA/FDA space in high-molecular grade testing field very well.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free